Skip to main content

Animations

MJFF Publications

5361 - 5370 of 8823 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2020
  • 2011
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115355
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41591-025-03565-2
    Citation Count: 70
  • Summary Details
    OPEN
    Title: KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa304
    Citation Count: 105
  • Summary Details
    OPEN
    Title: BAX inhibitor‐1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2011.318
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson’s Disease: Data from the PPMI Study
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-191860
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Happiness: A Novel Outcome in Parkinson Studies?
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-201999
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease Psychosis
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-202047
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and Design
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-202019
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Olfaction in LRRK2 Linked Parkinson’s Disease: Is It Different from Idiopathic Parkinson’s Disease?
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-201972
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Clinical Trial Highlights – Infusion Therapies
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-199005
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.